Founder and managing director of Chanelle Pharma Michael Burke.
ADVERTISEMENT
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a UK- and Dublin-based private equity firm.
Chanelle, founded in Galway by Burke in 1985, now employs 730 people across its sites in Ireland, the UK, Europe and Jordan.
The company is a leading maker of generic pharmaceuticals for both human and veterinary customers.
ADVERTISEMENT
Following completion of the deal, which will be subject to approval from the Competition and Consumer Protection Commission, Burke will retire from the company.
There will be no other changes for management or employees as a result of the deal.
Global presence
Speaking for Exponent, which reportedly offered in the region of €300m for Chanelle, partner David McGovern said that they “look forward to working closely with Chanelle's management team to strengthen its global presence and invest in its capabilities”.
Burke said: “Having dedicated my life to building Chanelle Pharma into a global company, I have decided the time is right to allow new owners to lead the company into its next phase of growth.”
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a UK- and Dublin-based private equity firm.
Chanelle, founded in Galway by Burke in 1985, now employs 730 people across its sites in Ireland, the UK, Europe and Jordan.
The company is a leading maker of generic pharmaceuticals for both human and veterinary customers.
Following completion of the deal, which will be subject to approval from the Competition and Consumer Protection Commission, Burke will retire from the company.
There will be no other changes for management or employees as a result of the deal.
Global presence
Speaking for Exponent, which reportedly offered in the region of €300m for Chanelle, partner David McGovern said that they “look forward to working closely with Chanelle's management team to strengthen its global presence and invest in its capabilities”.
Burke said: “Having dedicated my life to building Chanelle Pharma into a global company, I have decided the time is right to allow new owners to lead the company into its next phase of growth.”
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS